CSB 2.008 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 5-20-24; correction made under s. 35.17, Stats., Register June 2024 No. 822.
CSB 2.009CSB 2.009Addition of 2 Synthetic Benzimidazole-Opioids to Schedule I. Section 961.14 (2) (xm) 7e. and 7m., Stats., are created to read:
961.14 (2) (xm) 7e. N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
961.14 (2) (xm) 7m. N-piperidinyl etonitazene also known as etonitazepipne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole).
CSB 2.009 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register October 2024 No. 826, eff. 10-21-24.
CSB 2.011CSB 2.011Addition of Ethylphenidate to Schedule I. Section 961.14 (7) (u), Stats., is created to read:
961.14 (7) (u) Ethyl 2-phenyl-2-(piperidin-2-yl)acetate, commonly known as Ethylphenidate.
CSB 2.011 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register December 2024 No. 828, eff. 12-16-24; renumbered to CSB 2.011 under s. 13.92 (4) (b) 1., Stats., Register April 2025 No. 832.
CSB 2.012CSB 2.012Addition of 7 Fentanyl Related Substances to Schedule I. Section 961.14 (2) (nd) 8m, 12p, 16h, 16q, 16r, 17d, and 18m are created to read:
961.14 (2) (nd) 8m. Beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide);
12p. Meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
16h. Ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
16q. Ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
16r. Para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide;
17d. Para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide);
18m. Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophen-2-carboxamide);
History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2025 No. 832, eff. 3-31-25; renumbered from CSB 2.005 (1) under s. 13.92 (4) (b) 1., Stats., Register April 2025 No. 832.
APPENDIX
CSB 2.012 NoteNote: This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.
CSB 2.012 NoteCSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s. 161.16, Stats., schedule II in sub. (6) which subsection is hereby created.
CSB 2.012 NoteNote: See Chapter 206, Laws of 1981 sections 29 and 31.
CSB 2.012 HistoryHistory: Cr. Register, June, 1973, No. 210, eff. 7-1-73.
CSB 2.012 NoteCSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:
CSB 2.012 Note(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.012 Note(a) Benzphetamine
CSB 2.012 Note(b) Chlorphentermine
CSB 2.012 Note(c) Clortermine
CSB 2.012 Note(d) Mazindol
CSB 2.012 Note(e) Phendimetrazine